Stock Quotes in this Article: CBLI, RNN, YUME

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

>>5 Hated Earnings Stocks You Should Love

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>5 Rocket Stocks to Buy This Week

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

YuMe

YuMe (YUME) provides digital video brand advertising solutions. This stock closed up 10.3% to $7.81 in Tuesday's trading session.

Tuesday's Range: $7.11-$7.88

52-Week Range: $5.79-$12.08

Tuesday's Volume: 591,000

Three-Month Average Volume: 238,225

From a technical perspective, YUME exploded higher here right off its 50-day moving average of $7.19 with above-average volume. This move pushed shares of YUME into breakout territory, since the stock took out and closed above some near-term overhead resistance at $7.88. This move is starting to push shares of YUME within range of triggering another major breakout trade. That trade will hit if YUME manages to take out Tuesday's high of $7.88 to some more near-term overhead resistance at $8.09 with high volume.

Traders should now look for long-biased trades in YUME as long as it's trending above Tuesday's low of $7.11 or above $7 and then once it sustains a move or close above those breakout levels with volume that hits near or above 238,225 shares. If that breakout gets underway soon, then YUME will set up to re-test or possibly take out its next major overhead resistance levels at $8.80 to $9, or even $9.40 to $10.

Rexahn Pharmaceuticals

Rexahn Pharmaceuticals (RNN), clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs. This stock closed up 4.6% to $1.34 in Tuesday's trading session.

Tuesday's Range: $1.29-$1.38

52-Week Range: $0.28-$1.85

Tuesday's Volume: 8.66 million

Three-Month Average Volume: 11.78 million

From a technical perspective, RNN spiked notably higher here right above some near-term support at $1.20 with lighter-than-average volume. This stock has found some support and buying interest over the last few weeks each time it's pulled back to around $1.20. Market players should now look for a continuation move higher in the short-term if RNN manages to take out Tuesday's high of $1.38 to more near-term resistance at $1.40 with high volume.

Traders should now look for long-biased trades in RNN as long as it's trending above some near-term support at $1.22 and then once it sustains a move or close above $1.38 to $1.40 volume that hits near or above 11.78 million shares. If that move starts soon, then RNN will set up to re-test or possibly take out its next major overhead resistance levels at $1.52 to $1.60. Any high-volume move above those levels will then give RNN a chance to tag its 52-week high at $1.85.

Cleveland BioLabs

Cleveland BioLabs (CBLI), a clinical-stage biotechnology company, engages in the research, development, and commercialization of products that have the potential to treat cancer, reduce death from total body irradiation, and counteract the genotoxic effects of radio- and chemotherapies for oncology patients. This stock closed up 3.1% to 71 cents per share in Tuesday's trading session.

Tuesday's Range: $0.67-$0.72

52-Week Range: $0.63-$2.28

Thursday's Volume: 675,000

Three-Month Average Volume: 566,620

From a technical perspective, CBLI bounced higher here right above some near-term support at 66 cents per share with above-average volume. This stock has been forming a major bottoming chart pattern over the last two months, with shares finding buying interest each time the stock has pulled back towards 66 to 63 cents per share. Market players should now look for a continuation move higher in the short-term of CBLI manages to take out Tuesday's high of 72 cents per share with high volume.

Traders should now look for long-biased trades in CBLI as long as it's trending above 66 cents per share and then once it sustains a move or close above 72 cents per share with volume that hits near or above 566,620 shares. If we get that move soon, then CBLI will set up to re-test or possibly take out its next major overhead resistance levels at 76 cents per share to its 50-day moving average of 82 cents per share. Any high-volume move above those levels and 85 cents per share will then give CBLI chance to re-fill some of its previous gap-down-day zone from January that started just above $1.10.

To see more stocks that are making notable moves higher, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com.

You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.